{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MD simulations", "VEGFR-2", "anticancer", "apoptosis", "immunomodulatory", "molecular docking", "semisynthesis", "theobromine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37466069", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.4155/fmc-2023-0089"], "Journal": {"ISSN": "1756-8927", "JournalIssue": {"Volume": "15", "Issue": "14", "PubDate": {"Year": "2023", "Month": "Jul"}}, "Title": "Future medicinal chemistry", "ISOAbbreviation": "Future Med Chem"}, "ArticleTitle": "New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations.", "Pagination": {"StartPage": "1233", "EndPage": "1250", "MedlinePgn": "1233-1250"}, "Abstract": {"AbstractText": ["<b>Background:</b> VEGFR-2 is one of the most effective targets in cancer treatment. <b>Aim:</b> The design and semi-synthesis of new theobromine derivatives as potential VEGFR-2 inhibitors. <b>Methods:</b> <i>In vitro</i> and <i>in silico</i> evaluation of the synthesized compounds. <b>Results:</b> Compound <b>5b</b> demonstrated excellent antiproliferative and VEGFR-2 inhibitory effects with significant apoptotic activity. It modulated the immune response by increasing IL-2 and reducing TNF-\u03b1 levels. Docking and molecular dynamics simulations revealed the compound's binding affinity with VEGFR-2. Lastly, computational absorption, distribution, metabolism, excretion and toxicity studies indicated the high potential of compound <b>5b</b> for drug development. <b>Conclusion:</b> Compound <b>5b</b> could be a promising anticancer agent targeting VEGFR-2."]}, "AuthorList": [{"Identifier": ["0000-0002-6620-241X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Mahdy", "ForeName": "Hazem A", "Initials": "HA"}, {"Identifier": ["0000-0003-0893-6703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0003-0630-709X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Taghour", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": ["0000-0003-4270-616X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Elwan", "ForeName": "Alaa", "Initials": "A"}, {"Identifier": ["0000-0002-2016-0728"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Dahab", "ForeName": "Mohammed A", "Initials": "MA"}, {"Identifier": ["0000-0002-6475-6937"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry & Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Elkady", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": ["0000-0001-7065-5553"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry & Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Elsakka", "ForeName": "Elsayed Ge", "Initials": "EG"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0001-6489-6035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, PO Box 84428, Riyadh, 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Bshra A", "Initials": "BA"}, {"Identifier": ["0000-0001-7875-7538"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biophysics Department, Faculty of Science, Cairo University, Cairo, 12613, Egypt."}], "LastName": "Ibrahim", "ForeName": "Ibrahim M", "Initials": "IM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy & Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering & Biotechnology Research Institute, City of Scientific Research & Technological Applications (SRTA-City), Alexandria, 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Future Med Chem", "NlmUniqueID": "101511162", "ISSNLinking": "1756-8919"}, "ChemicalList": [{"RegistryNumber": "OBD445WZ5P", "NameOfSubstance": "Theobromine"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Vascular Endothelial Growth Factor Receptor-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Theobromine"}, {"QualifierName": [], "DescriptorName": "Vascular Endothelial Growth Factor Receptor-2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Design"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "10", "Day": "23", "Hour": "0", "Minute": "44"}, {"Year": "2023", "Month": "7", "Day": "19", "Hour": "13", "Minute": "6"}, {"Year": "2023", "Month": "7", "Day": "19", "Hour": "6", "Minute": "37"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37466069", "10.4155/fmc-2023-0089"]}}], "PubmedBookArticle": []}